Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Kerr

Showing results (51-60 of 137) with videos related to

Pageof 14
Sort By:
The New Zealand Medical Journal|January 17, 2020
Trends in length of stay following acute coronary syndrome hospitalisation in New Zealand 2006-2016: ANZACS-QI 32 studyTom Kai Ming Wang, Corina Grey, Yannan Jiang, et al.
Heart, Lung & Circulation|October 21, 2015
Relationships between Anticoagulation, Risk Scores and Adverse Outcomes in Dialysis Patients with Atrial FibrillationTom Kai Ming Wang, Janarthanan Sathananthan, Mark Marshall, et al.
JMIR Rehabilitation and Assistive Technologies|May 14, 2025
Co-Designed Digital Device for Tracking Rehabilitation Dosage in a Clinical Environment After Stroke: Mixed Methods Validity and Feasibility StudyFiona Boyd, Gillian Sweeney, Mark Barber, et al.
Heart, Lung & Circulation|January 25, 2020
Contrasting Trends in Acute Coronary Syndrome Hospitalisation and Coronary Revascularisation in New Zealand 2006-2016: A National Data Linkage Study (ANZACS-QI 27)Tom Kai Ming Wang, Corina Grey, Yannan Jiang, et al.
Gait & Posture|January 15, 2011
Measuring foot placement and clearance during stair descentJennifer Muhaidat, Andrew Kerr, Danny Rafferty, et al.
The New Zealand Medical Journal|September 15, 2007
The impact of New Zealand CVD risk chart adjustments for family history and ethnicity on eligibility for treatment (PREDICT CVD-5)Susan Wells, Andrew Kerr, Joanna Broad, et al.
Medical Physics|August 10, 2013
Cobalt-60 tomotherapy: clinical treatment planning and phantom dose delivery studiesSandeep Dhanesar, Johnson Darko, Chandra P Joshi, et al.
The New Zealand Medical Journal|August 23, 2014
Construction and use of mapping techniques to describe the geographical distribution of medication dispensing for the secondary prevention of atherosclerotic CVD in New Zealand: VIEW-2Daniel J Exeter, Jinfeng Zhao, Grant Hanham, et al.
The New Zealand Medical Journal|July 21, 2017
30-day mortality after percutaneous coronary intervention in New Zealand public hospitals (ANZACS-QI 18)Andrew Kerr, Michael Ja Williams, Harvey White, et al.
Journal of Medical Physics|January 26, 2010
The role of Cobalt-60 in modern radiation therapy: Dose delivery and image guidanceL John Schreiner, Chandra P Joshi, Johnson Darko, et al.
Pageof 14

Showing results (51-60 of 137) with videos related to

Sort By:
Pageof 14
The New Zealand Medical Journal|January 17, 2020
Trends in length of stay following acute coronary syndrome hospitalisation in New Zealand 2006-2016: ANZACS-QI 32 studyTom Kai Ming Wang, Corina Grey, Yannan Jiang, et al.
Heart, Lung & Circulation|October 21, 2015
Relationships between Anticoagulation, Risk Scores and Adverse Outcomes in Dialysis Patients with Atrial FibrillationTom Kai Ming Wang, Janarthanan Sathananthan, Mark Marshall, et al.
JMIR Rehabilitation and Assistive Technologies|May 14, 2025
Co-Designed Digital Device for Tracking Rehabilitation Dosage in a Clinical Environment After Stroke: Mixed Methods Validity and Feasibility StudyFiona Boyd, Gillian Sweeney, Mark Barber, et al.
Heart, Lung & Circulation|January 25, 2020
Contrasting Trends in Acute Coronary Syndrome Hospitalisation and Coronary Revascularisation in New Zealand 2006-2016: A National Data Linkage Study (ANZACS-QI 27)Tom Kai Ming Wang, Corina Grey, Yannan Jiang, et al.
Gait & Posture|January 15, 2011
Measuring foot placement and clearance during stair descentJennifer Muhaidat, Andrew Kerr, Danny Rafferty, et al.
The New Zealand Medical Journal|September 15, 2007
The impact of New Zealand CVD risk chart adjustments for family history and ethnicity on eligibility for treatment (PREDICT CVD-5)Susan Wells, Andrew Kerr, Joanna Broad, et al.
Medical Physics|August 10, 2013
Cobalt-60 tomotherapy: clinical treatment planning and phantom dose delivery studiesSandeep Dhanesar, Johnson Darko, Chandra P Joshi, et al.
The New Zealand Medical Journal|August 23, 2014
Construction and use of mapping techniques to describe the geographical distribution of medication dispensing for the secondary prevention of atherosclerotic CVD in New Zealand: VIEW-2Daniel J Exeter, Jinfeng Zhao, Grant Hanham, et al.
The New Zealand Medical Journal|July 21, 2017
30-day mortality after percutaneous coronary intervention in New Zealand public hospitals (ANZACS-QI 18)Andrew Kerr, Michael Ja Williams, Harvey White, et al.
Journal of Medical Physics|January 26, 2010
The role of Cobalt-60 in modern radiation therapy: Dose delivery and image guidanceL John Schreiner, Chandra P Joshi, Johnson Darko, et al.
Pageof 14